<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Multidiscip Healthc</journal-id><journal-id journal-id-type="iso-abbrev">J Multidiscip Healthc</journal-id><journal-id journal-id-type="pmc-domain-id">1406</journal-id><journal-id journal-id-type="pmc-domain">jmulthealth</journal-id><journal-id journal-id-type="publisher-id">jmdh</journal-id><journal-title-group><journal-title>Journal of Multidisciplinary Healthcare</journal-title></journal-title-group><issn pub-type="epub">1178-2390</issn><publisher><publisher-name>Dove Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12118490</article-id><article-id pub-id-type="pmcid-ver">PMC12118490.1</article-id><article-id pub-id-type="pmcaid">12118490</article-id><article-id pub-id-type="pmcaiid">12118490</article-id><article-id pub-id-type="pmid">40438565</article-id><article-id pub-id-type="doi">10.2147/JMDH.S509971</article-id><article-id pub-id-type="publisher-id">509971</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Smoking, Obesity, and Post-Cessation Weight Gain: Neurobiological Intersection and Treatment Recommendations</article-title><alt-title alt-title-type="running-authors">Golden and Davis</alt-title><alt-title alt-title-type="running-title">Golden and Davis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Golden</surname><given-names initials="A">Angela</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davis</surname><given-names initials="JM">James M</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>NP From Home LLC and NP Obesity Treatment Clinic</institution>, <addr-line>Flagstaff</addr-line>, <addr-line>AZ</addr-line>, <country>USA</country></aff><aff id="aff0002"><label>2</label><institution>Duke University School of Medicine</institution>, <addr-line>Durham</addr-line>, <addr-line>NC</addr-line>, <country>USA</country></aff><aff id="aff0003"><label>3</label><institution>Duke Cancer Institute</institution>, <addr-line>Durham</addr-line>, <addr-line>NC</addr-line>, <country>USA</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: James M Davis, <institution>Duke University School of Medicine, Duke Cancer Institute</institution>, <addr-line>2424 Erwin Road, Suite 201</addr-line>, <addr-line>Durham</addr-line>, <addr-line>NC</addr-line>, <addr-line>27705</addr-line>, <country>USA</country>, Email james.m.davis@duke.edu</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>18</volume><issue-id pub-id-type="pmc-issue-id">479228</issue-id><fpage>2889</fpage><lpage>2900</lpage><history><date date-type="received"><day>07</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>08</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>24</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-29 22:25:37.673"><day>29</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Golden and Davis.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Golden and Davis.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#8211; Non Commercial (unported, v4.0) License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jmdh-18-2889.pdf"/><abstract><title>Abstract</title><p>In the US, 28.8 million adults currently smoke cigarettes, and approximately 1.25 billion people use tobacco globally. Unfortunately, post-cessation weight gain is a substantial barrier to smoking cessation and sustained abstinence. Among people who smoke, 36% meet the body mass index (BMI) criteria for obesity and over 50% meet the waist circumference criteria for central obesity. Despite this, primary care providers currently have limited guidance on how to best treat their patients who want to quit smoking without post-cessation weight gain. There are common neurobiologic and endocrine dysregulations in nicotine dependence and weight gain. For example, nicotine dependence and obesity are both associated with dysregulation in hypothalamic neuropeptide systems and dopaminergic pathways. Medications for nicotine dependence act on dopaminergic pathways and hypothalamic pro-opiomelanocortin (POMC) cells. Similarly, medications for obesity may increase dopamine and norepinephrine signaling and stimulate POMC activity. A unique medication, the fixed-dose extended-release combination of naltrexone and bupropion, supports both smoking cessation and weight loss by increasing dopamine and norepinephrine signaling and stimulating POMC-producing cells. This narrative review outlines neurobiologic mechanisms common to smoking and obesity and compares the effects of available pharmacotherapies on dopaminergic system and neuroendocrine dysregulation. Finally, this review outlines factors that primary care professionals should consider when treating people who want to stop smoking but are at risk of post-cessation weight gain.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>brain mechanisms</kwd><kwd>pharmacotherapy</kwd><kwd>primary care</kwd><kwd>smoking cessation</kwd><kwd>weight gain</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Currax Pharmaceuticals, LLC</institution></institution-wrap></funding-source></award-group><funding-statement>The authors were not compensated for their participation in this project. Medical writing and editorial support were provided by Breanne E. Pirino, PhD, of Red Nucleus, and were funded by Currax Pharmaceuticals, LLC.</funding-statement></funding-group><counts><fig-count count="1"/><ref-count count="143"/><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Approximately 1.25 billion people 15 years and older globally use tobacco, and 28.8 million adults in the US currently smoke cigarettes.<xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0002" ref-type="bibr">2</xref> Among people who smoke in the US, 68% express a desire to stop smoking.<xref rid="cit0001" ref-type="bibr">1</xref> Unfortunately, 77% to 86% of people who stop smoking gain weight in the first year of abstinence.<xref rid="cit0003" ref-type="bibr">3</xref> In the US, 36% of people who smoke also have obesity,<xref rid="cit0004" ref-type="bibr">4</xref> and obesity affects over 890 million adults globally.<xref rid="cit0005" ref-type="bibr">5</xref> For individuals with obesity, additional weight gain may present a substantial health risk and a barrier to smoking cessation. Thus, primary care professionals who are helping their patients quit smoking must often address the potential for post-cessation weight gain.</p><p>Studies have shown an association between chronic smoking and lower body weight.<xref rid="cit0006" ref-type="bibr">6&#8211;8</xref> Conversely, smoking cessation is associated with weight gain and higher body weight.<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0009" ref-type="bibr">9&#8211;11</xref> According to a 2012 meta-analysis, mean post-cessation weight gain 1 year after quitting smoking is 4.67 kg (10.3 lb), and 13% to 14% of people who quit smoking gain more than 10 kg (22 lb).<xref rid="cit0003" ref-type="bibr">3</xref> People with higher baseline body weights tend to have greater post-cessation weight gain than those with lower baseline body weights,<xref rid="cit0012" ref-type="bibr">12</xref> and post-cessation weight gain may result in patients meeting the criteria for obesity (body mass index [BMI] &#8805;30) or a higher class of obesity.</p><p>Post-cessation weight gain is a significant health concern, regardless of a patient&#8217;s BMI, as it is associated with an increase in hypertension<xref rid="cit0013" ref-type="bibr">13</xref> and type 2 diabetes.<xref rid="cit0014" ref-type="bibr">14</xref> Compared with BMI, central obesity is more predictive of cardiovascular disease and all-cause mortality.<xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0016" ref-type="bibr">16</xref> People who currently and formerly smoked were more likely to have central obesity (&#8805;85 cm for women and &#8805;90 cm for men) than those who never smoked, according to an analysis of the Korea National Health and Nutrition Examination Survey.<xref rid="cit0017" ref-type="bibr">17</xref> Central obesity is generally defined as a waist circumference &#8805;105 cm for women and &#8805;110 cm for men (with lower thresholds for people with Asian ancestry) or waist-to-hip ratio of &#8805;0.85 for women and &#8805;0.95 for men.<xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0016" ref-type="bibr">16</xref> Among people who smoke, 54% had a waist circumference in the central obesity category (defined as &gt;35 inches or 89 cm for women and &gt;40 inches or 102 cm for men) according to an analysis of the US National Health and Nutrition Examination Survey (NHANES).<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0017" ref-type="bibr">17</xref> The health risks associated with central obesity, which are exacerbated by smoking, highlight the importance of addressing post-cessation weight gain with patients who want to stop smoking to prevent additional health consequences.</p><p>The long-term benefits of smoking cessation substantially outweigh the health risks associated with post-cessation weight gain;<xref rid="cit0018" ref-type="bibr">18</xref> however, patients who express concerns about post-cessation weight gain have lower rates of smoking abstinence.<xref rid="cit0019" ref-type="bibr">19</xref> Moreover, weight gain is associated with relapse back to smoking.<xref rid="cit0020" ref-type="bibr">20&#8211;22</xref> Women report that they are willing to gain a mean of 2.3 kg (5 lb) after smoking cessation, while men report that they are willing to gain a mean of 4.9 kg (10 lb), with a rising risk of smoking relapse above these thresholds.<xref rid="cit0023" ref-type="bibr">23</xref> A recent meta-analysis found that managing weight gain during smoking cessation significantly improved smoking abstinence rates.<xref rid="cit0024" ref-type="bibr">24</xref> Unfortunately, the medications currently available for smoking cessation have relatively small effects on post-cessation weight gain (&lt;1 kg at 1 year).<xref rid="cit0025" ref-type="bibr">25&#8211;27</xref> A medication that could aid in smoking cessation and attenuate or eliminate post-cessation weight gain would have undeniable benefits for people who want to stop smoking.</p><p>In this review, we provide an overview of evidence-based treatments for patients who want to quit smoking and reduce or eliminate post-cessation weight gain. We outline key underlying brain mechanisms implicated in nicotine dependence and weight gain, including effects on hypothalamic systems and dopaminergic pathways. We then explore the role of available medications that might be used by primary care providers for smoking cessation, obesity, and post-cessation weight gain.</p></sec><sec id="s0002"><title>Neurobiology of Weight Regulation, Obesity, and Nicotine Dependence</title><p>Activity in the hypothalamus and mesolimbic &#8220;reward&#8221; pathway is central to nicotine dependence as well as central hunger, satiety, and the motivation to eat.<xref rid="cit0028" ref-type="bibr">28&#8211;36</xref> Obesity is now recognized as being primarily a neuroendocrine disease<xref rid="cit0037" ref-type="bibr">37</xref> that results in impaired systems of hunger and satiety<xref rid="cit0038" ref-type="bibr">38</xref> as well as metabolic disruption.<xref rid="cit0039" ref-type="bibr">39</xref> While hypothalamic systems are generally associated with homeostatic eating (food consumption in response to metabolic signals), the mesolimbic reward system is typically associated with non-homeostatic, &#8220;hedonic&#8221; eating (food consumption for its rewarding properties, regardless of metabolic status or the food&#8217;s nutritional value).<xref rid="cit0040" ref-type="bibr">40</xref> More specifically, the hypothalamus integrates peripheral input regarding the body&#8217;s energy balance and then responds to this input through a variety of neuropeptides and connections with mesolimbic pathways.<xref rid="cit0041" ref-type="bibr">41&#8211;43</xref> In the mesolimbic pathway, activation of neurons in the ventral tegmental area (VTA) results in dopamine release into the nucleus accumbens (NAc), prefrontal cortex, and other brain structures, ultimately giving rise to appetitive and reward-motivated behaviors, such as eating and smoking (<xref rid="f0001" ref-type="fig">Figure 1A</xref>).<xref rid="cit0044" ref-type="bibr">44</xref> Addictive substances, like nicotine, &#8220;hijack&#8221; neurobiologic systems that can regulate reward pathways and appetitive processes governing food intake.<xref rid="cit0045" ref-type="bibr">45&#8211;47</xref>
<fig position="float" id="f0001" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><p>Neurobiology of obesity and smoking addiction. (<bold>A</bold>) The hypothalamus interacts with the mesolimbic pathway via connections with the VTA and NAc. Smoking addiction upregulates the nAChR, can bidirectionally impact insulin sensitivity, and downregulates dopamine and norepinephrine signaling. Obesity also downregulates dopamine signaling, reduces insulin sensitivity, and increases connectivity between the NAc and hypothalamus. Adapted from Xu H, Yang F. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry. 2022;12(1):464. (<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link></underline>).<xref rid="cit0048" ref-type="bibr">48</xref> (<bold>B</bold>) In the arcuate nucleus of the hypothalamus (shown in a coronal brain slice), POMC- and AgRP-producing neurons reciprocally inhibit one another and can be stimulated or inhibited by insulin signaling and stimulated by nicotine, GLP-1, bupropion, and sympathomimetics to promote satiety. In obesity, insulin preferentially inhibits POMC activity. Adapted from Baik JH. Dopaminergic control of the feeding circuit. Endocrinol Metab (Seoul). 2021;36(2):229&#8211;239. (<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri">https://creativecommons.org/licenses/by-nc/4.0/</ext-link></underline>).<xref rid="cit0049" ref-type="bibr">49</xref></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="JMDH-18-2889-g0001.jpg"/><attrib><bold>Abbreviations</bold>: AgRP, agouti-related peptide; CART, cocaine and amphetamine regulated transcript; DA, dopamine; GLP-1, glucagon-like peptide 1; NAc, nucleus accumbens; nAChR, nicotinic acetylcholine receptor; NE, norepinephrine; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; VTA, ventral tegmental area; 3V, third ventricle.</attrib></fig></p><sec id="s0002-s2001"><title>Neurobiology of Weight Regulation</title><p>Energy balance and weight regulation are controlled in part by communication between the hypothalamic neuroendocrine system and the mesolimbic reward pathway. In the hypothalamus, first-order neurons in the arcuate nucleus receive information about the body&#8217;s energy balance by detecting serum levels of insulin, leptin, and glucagon-like peptide 1 (GLP-1).<xref rid="cit0050" ref-type="bibr">50</xref>,<xref rid="cit0051" ref-type="bibr">51</xref> One subpopulation of these arcuate nucleus neurons produces the orexigenic (hunger-inducing) neuropeptide, agouti-related peptide (AgRP), while another subpopulation produces the anorexigenic (satiety-inducing) neuropeptide, pro-opiomelanocortin (POMC). These POMC and AgRP neurons project to other areas of the hypothalamus and the brainstem to control and coordinate hunger and satiety responses as well as energy expenditure and other metabolic processes.<xref rid="cit0041" ref-type="bibr">41</xref>,<xref rid="cit0052" ref-type="bibr">52&#8211;54</xref> Despite the fact that appetitive pathways are classified as &#8220;hedonic&#8221; and satiety pathways are classified as &#8220;homeostatic&#8221;, the 2 systems are in constant communication.<xref rid="cit0055" ref-type="bibr">55</xref> One component of this interactive neuroendocrine system is activation of the mesolimbic system.<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0057" ref-type="bibr">57</xref> Neurons in the VTA express dopamine and receptors for hypothalamic neuropeptides involved in hunger and satiety, such as the POMC product melanocortin.<xref rid="cit0058" ref-type="bibr">58</xref> These neuropeptides activate the VTA, which in turn releases dopamine into the NAc and can promote eating.<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0057" ref-type="bibr">57</xref> Taken together, the hypothalamic neuroendocrine system activates and regulates the mesolimbic reward pathway in the brain to regulate food intake.</p></sec><sec id="s0002-s2002"><title>Neuroendocrine Dysregulation in Obesity</title><p>As a neuroendocrine disorder, obesity is associated primarily with dysregulation of the neuroendocrine system, with some involvement of the mesolimbic brain pathways.<xref rid="cit0037" ref-type="bibr">37&#8211;39</xref> The volume of the hypothalamus, including the energy-sensing arcuate nucleus, is greater in people with a BMI &#8805;25 than in those with a BMI &lt;25.<xref rid="cit0059" ref-type="bibr">59</xref> Moreover, higher BMI and central obesity (measured by waist circumference) are associated with greater disruptions in hypothalamic cellular structures.<xref rid="cit0060" ref-type="bibr">60</xref>,<xref rid="cit0061" ref-type="bibr">61</xref> These structural disruptions may be caused by inflammation, given that hypothalamic inflammation is associated with higher BMI, greater central obesity, greater visceral fat, and metabolic disease.<xref rid="cit0062" ref-type="bibr">62</xref> Additionally, people with obesity (BMI &gt;25) compared to people with a BMI &lt;25&#160;have greater functional connectivity between the hypothalamus and the NAc.<xref rid="cit0055" ref-type="bibr">55</xref> This increased connectivity between homeostatic (hypothalamus) and mesolimbic (NAc) regions may contribute to hypothalamic and mesolimbic dysregulation.</p><p>Individuals with obesity also show lower activation of circuits involved in the response to food consumption, with decreased dopamine binding in the ventral striatum.<xref rid="cit0063" ref-type="bibr">63</xref> Some studies have associated obesity with reduced dopamine receptor availability in the striatum.<xref rid="cit0030" ref-type="bibr">30</xref>,<xref rid="cit0031" ref-type="bibr">31</xref> In contrast, a recent meta-analysis found that differences in dopamine receptor availability between individuals with obesity and those without obesity were only consistent among those with a BMI &#8805;40.<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0065" ref-type="bibr">65</xref> On the other hand, a 2019 meta-analysis found that stimulating dopamine receptors led to decreases in body weight, BMI, and waist circumference in patients with prolactinomas who were treated with dopamine agonists.<xref rid="cit0066" ref-type="bibr">66</xref> Thus, the available evidence suggests a link between a dysregulated dopaminergic system and obesity in some people, which may drive overconsumption of highly palatable foods and be improved by restoring dopamine transmission.</p></sec><sec id="s0002-s2003"><title>Neurobiology of Nicotine Dependence</title><p>In the brain, nicotine binds and activates nicotinic acetylcholine receptors (nAChRs), receptors that are normally activated by acetylcholine.<xref rid="cit0067" ref-type="bibr">67</xref>,<xref rid="cit0068" ref-type="bibr">68</xref> There is a high density of nAChRs in brain structures associated with motivation, including the VTA, NAc, prefrontal cortex, and hypothalamus.<xref rid="cit0069" ref-type="bibr">69</xref>,<xref rid="cit0070" ref-type="bibr">70</xref> When nicotine binds to nAChRs, it triggers dopamine release from the VTA to the NAc,<xref rid="cit0067" ref-type="bibr">67</xref>,<xref rid="cit0068" ref-type="bibr">68</xref> enhancing reward and motivation. Additionally, nicotine increases POMC neuron activity in the hypothalamus to promote satiety.<xref rid="cit0032" ref-type="bibr">32</xref> Thus, nicotine affects both hypothalamic and mesolimbic systems.</p><p>Chronic nicotine use leads to dysregulation of both hypothalamic and mesolimbic systems and precipitates symptoms of nicotine withdrawal during smoking abstinence. Studies have found that smoking leads to an upregulation of nAChRs throughout the brain, with people who smoke expressing 27% greater levels of nAChRs in the striatum compared with people who do not smoke.<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0029" ref-type="bibr">29</xref> The degree of nAChR upregulation is associated with the severity of withdrawal symptoms and difficulty quitting smoking.<xref rid="cit0071" ref-type="bibr">71</xref> With extensive nAChR upregulation, acetylcholine signaling is insufficient to bind the larger population of nAChRs, and the resulting understimulation results in nicotine withdrawal symptoms during smoking abstinence.<xref rid="cit0072" ref-type="bibr">72</xref> While smoking upregulates nAChRs, it downregulates dopamine receptors, leading to decreased reward from acetylcholine and nicotine and the experience of nicotine tolerance.<xref rid="cit0073" ref-type="bibr">73&#8211;75</xref></p><p>The severity of nicotine withdrawal symptoms is highly predictive of smoking relapse.<xref rid="cit0074" ref-type="bibr">74</xref> Clinically, nicotine withdrawal commonly includes irritability, insomnia, anxiety, difficulty concentrating, agitation, fatigue, depressed mood, restlessness, hunger, and weight gain.<xref rid="cit0076" ref-type="bibr">76</xref> Nicotine withdrawal is associated with decreased signaling of dopamine,<xref rid="cit0077" ref-type="bibr">77</xref>,<xref rid="cit0078" ref-type="bibr">78</xref> norepinephrine, serotonin, and other neurotransmitters in mesolimbic brain structures. In contrast to the stimulation of reward systems seen in acute nicotine use (eg, in a nicotine-na&#239;ve patient), chronic nicotine use is associated with decreased mesolimbic reward processing<xref rid="cit0079" ref-type="bibr">79</xref> and dysregulation of mesolimbic reward systems.<xref rid="cit0067" ref-type="bibr">67</xref>,<xref rid="cit0068" ref-type="bibr">68</xref> Pharmacotherapies that treat nicotine withdrawal (nicotine replacement, bupropion) lead to increased signaling of dopamine, norepinephrine, and other neurotransmitters.<xref rid="cit0072" ref-type="bibr">72</xref>,<xref rid="cit0080" ref-type="bibr">80&#8211;82</xref></p></sec><sec id="s0002-s2004"><title>The Neurobiological Intersection of Nicotine Dependence and Obesity</title><p>Both nicotine dependence and weight regulation occur through neuroendocrine and mesolimbic pathways. A pathway found in both is the hypothalamic neuropeptide system.<xref rid="cit0032" ref-type="bibr">32</xref>,<xref rid="cit0043" ref-type="bibr">43</xref> Specifically, nicotine activates the POMC system, which has been known to promote satiety;<xref rid="cit0032" ref-type="bibr">32</xref> however, insulin can inhibit POMC activity in people with obesity and promote hunger (<xref rid="f0001" ref-type="fig">Figure 1B</xref>).<xref rid="cit0039" ref-type="bibr">39</xref> Similarly, increased levels of AgRP have been associated with food cravings,<xref rid="cit0083" ref-type="bibr">83</xref> and AgRP-producing neuron activity can promote insulin resistance.<xref rid="cit0084" ref-type="bibr">84</xref> Nicotine can either enhance or reduce insulin sensitivity,<xref rid="cit0085" ref-type="bibr">85</xref> resulting in bidirectional effects on body weight.<xref rid="cit0086" ref-type="bibr">86</xref> For example, chronic nicotine use can either promote insulin sensitivity and decreased body weight or promote insulin resistance and increased body weight. Importantly, insulin resistance is associated with greater visceral fat accumulation, which may contribute to increased central obesity among some people who smoke.<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0086" ref-type="bibr">86</xref> Similarly, smoking more heavily (more cigarettes per day) is associated with increased rates of obesity and higher weight gain after smoking cessation.<xref rid="cit0087" ref-type="bibr">87</xref> Thus, while nicotine may promote satiety and lower body weight in some people via increased POMC activity, smoking may also lead to insulin resistance and increased central adiposity in other people, possibly via dysregulation of POMC neurons and insulin resistance. In addition to the association of smoking with dysregulation of metabolic processes, smoking cessation is commonly associated with weight gain due to the removal of the excitatory effects of nicotine on hypothalamic and metabolic systems.<xref rid="cit0088" ref-type="bibr">88</xref></p><p>The dopaminergic system is also implicated in weight gain and nicotine dependence.<xref rid="cit0030" ref-type="bibr">30</xref>,<xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0073" ref-type="bibr">73</xref>,<xref rid="cit0075" ref-type="bibr">75</xref> During nicotine withdrawal, people experience a hypodopaminergic state<xref rid="cit0078" ref-type="bibr">78</xref> that is quite similar to the hypodopaminergic state found in people with hedonic eating.<xref rid="cit0089" ref-type="bibr">89</xref> It is now hypothesized that reduced dopamine transmission may be a cause of food cravings.<xref rid="cit0090" ref-type="bibr">90</xref> Although there is conflicting evidence regarding the effects of smoking and smoking cessation on metabolic rate,<xref rid="cit0091" ref-type="bibr">91</xref>,<xref rid="cit0092" ref-type="bibr">92</xref> many people engage in increased hedonic eating during nicotine withdrawal,<xref rid="cit0093" ref-type="bibr">93</xref>,<xref rid="cit0094" ref-type="bibr">94</xref> possibly due to a hypodopaminergic state. In summary, smoking cessation and obesity are each independently associated with dysregulation of the dopaminergic system.<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0065" ref-type="bibr">65</xref> As such, people with obesity who also smoke commonly experience significant weight gain when trying to stop smoking.<xref rid="cit0003" ref-type="bibr">3</xref></p></sec></sec><sec id="s0003"><title>Treatments</title><sec id="s0003-s2001"><title>Evidence-Based Treatments for Smoking Cessation</title><p>Pharmacotherapies for smoking cessation target the nAChR or increase neurotransmitters (eg, dopamine and norepinephrine) that are low during nicotine withdrawal. Varenicline binds the nAChR at the nicotine binding site, blocking nicotine from binding to the nAChR and preventing nicotine-mediated reward.<xref rid="cit0095" ref-type="bibr">95</xref>,<xref rid="cit0096" ref-type="bibr">96</xref> Bupropion inhibits the reuptake of norepinephrine and dopamine in the neuronal synapse to increase mesolimbic activity, which is reduced during withdrawal.<xref rid="cit0081" ref-type="bibr">81</xref>,<xref rid="cit0082" ref-type="bibr">82</xref>,<xref rid="cit0097" ref-type="bibr">97</xref>,<xref rid="cit0098" ref-type="bibr">98</xref> Nicotine replacement therapies (eg, nicotine patch, gum, lozenge, inhaler, and nasal spray) increase dopamine transmission by binding to and activating nAChRs in the mesolimbic system to restore diminished dopamine transmission during withdrawal.<xref rid="cit0099" ref-type="bibr">99</xref>,<xref rid="cit0100" ref-type="bibr">100</xref> According to a 2013 meta-analysis, odds ratios for biochemically verified 6-month post-quit smoking abstinence rates compared with placebo were 2.88 for varenicline, 1.82 for bupropion, and 1.84 for nicotine replacement therapies.<xref rid="cit0101" ref-type="bibr">101</xref> Another option available for smoking cessation in the United Kingdom, Canada, and some European countries, cytisine, has a similar mechanism of action to varenicline (ie, nAChR blockade).<xref rid="cit0102" ref-type="bibr">102</xref> Cytisine was associated with biochemically verified smoking abstinence in 32.6% of patients compared with just 7% for patients receiving placebo at 12&#160;weeks in a randomized controlled trial.<xref rid="cit0103" ref-type="bibr">103</xref></p></sec><sec id="s0003-s2002"><title>Evidence-Based Treatments for Obesity</title><p>FDA-approved antiobesity medications work through several mechanisms. Nutrient-stimulated hormone&#8211;based pharmacotherapies (including the GLP-1 receptor [GLP-1R] agonists liraglutide, semaglutide, and tirzepatide) increase satiety via central effects.<xref rid="cit0104" ref-type="bibr">104&#8211;106</xref> While GLP-1R agonists do not readily cross the blood-brain barrier, some peripherally administered GLP-1R agonists like semaglutide may access certain brain regions.<xref rid="cit0107" ref-type="bibr">107&#8211;109</xref> In the brain, GLP-1R agonists can engage hypothalamic systems by preferentially targeting the GLP-1R in the hypothalamus, especially on POMC-producing neurons in the arcuate nucleus, promoting satiety.<xref rid="cit0107" ref-type="bibr">107</xref>,<xref rid="cit0110" ref-type="bibr">110</xref> These injectable medications lead to substantial weight loss, ranging from an 11% to 23% reduction in body weight in 56 to 72 weeks.<xref rid="cit0104" ref-type="bibr">104</xref>,<xref rid="cit0111" ref-type="bibr">111&#8211;114</xref> Sympathomimetics (including diethylpropion, phendimetrazine, benzphetamine, and phentermine + topiramate extended release [ER]) are amphetamine derivatives that increase the release of norepinephrine and, to a lesser extent, dopamine in the hypothalamus to stimulate POMC activity,<xref rid="cit0115" ref-type="bibr">115&#8211;120</xref> suppress appetite, and reduce body weight by 5% to 10% within 24 weeks.<xref rid="cit0116" ref-type="bibr">116&#8211;120</xref> Sympathomimetic medications have been associated with side effects such as increased blood pressure and insomnia.<xref rid="cit0116" ref-type="bibr">116</xref>,<xref rid="cit0121" ref-type="bibr">121</xref> Fixed-dose ER combination of naltrexone and bupropion (NB-ER) is a reward system regulator medication designed to treat obesity. The bupropion component of NB-ER increases the activity of norepinephrine and dopamine in the hypothalamus, which stimulates POMC cells.<xref rid="cit0115" ref-type="bibr">115</xref>,<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref> NB-ER may also prevent the subsequent inhibition of POMC cells by the inhibitory opioid neuropeptide beta-endorphin<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref> as well as alter mesolimbic dopamine activity via the naltrexone component.<xref rid="cit0124" ref-type="bibr">124</xref>,<xref rid="cit0125" ref-type="bibr">125</xref> NB-ER use results in an average of 5% to 12% weight loss in 56 weeks.<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref>,<xref rid="cit0126" ref-type="bibr">126</xref>,<xref rid="cit0127" ref-type="bibr">127</xref> To our knowledge, NB-ER is the only medication currently available that targets both the hypothalamic and mesolimbic systems involved in weight regulation.</p></sec><sec id="s0003-s2003"><title>Potential Treatments for Post-Cessation Weight Gain</title><p>Currently, the FDA has not approved a medication for the management of post-cessation weight gain. Compared with placebo, varenicline was associated with very modest attenuation of post-cessation weight gain over 12&#160;weeks, but effects were no longer significant after 1 year.<xref rid="cit0025" ref-type="bibr">25</xref> Similarly, the nicotine patch significantly attenuated post-cessation weight gain, but the effects only persisted while patients were using the patch.<xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0128" ref-type="bibr">128</xref> Bupropion has demonstrated the most promising attenuation of post-cessation weight gain, but effects were still modest (1.1 kg) at end of treatment.<xref rid="cit0027" ref-type="bibr">27</xref> While cytisine is used in some countries for smoking cessation, its effects on post-cessation weight gain have not been assessed.<xref rid="cit0103" ref-type="bibr">103</xref> A systematic review by the Cochrane Collaboration found mean attenuation of post-cessation weight gain for smoking cessation medications at end of treatment was &#8722;1.01 kg for bupropion, &#8722;0.52 kg for nicotine replacement therapy, and &#8722;0.23 kg for varenicline.<xref rid="cit0129" ref-type="bibr">129</xref> Although bupropion showed the largest attenuation of post-cessation weight gain, no medication thus far eliminates post-cessation weight gain.</p><p>Based on the known mechanisms of weight gain through hypothalamic and mesolimbic systems, several treatments are now being explored for smoking cessation and prevention of post-cessation weight gain. Despite the robust effects of nutrient-stimulated hormone&#8211;based medications on weight loss, recent studies have found that a GLP-1R agonist did not improve smoking cessation outcomes above those of placebo or varenicline alone.<xref rid="cit0130" ref-type="bibr">130</xref>,<xref rid="cit0131" ref-type="bibr">131</xref></p><p>Interestingly, NB-ER, which is approved by the FDA for the treatment of obesity, has also been shown to reduce nicotine withdrawal symptoms and food cravings.<xref rid="cit0132" ref-type="bibr">132</xref> As a reward system regulator, NB-ER can help to prevent weight gain 6 months after smoking cessation in individuals with obesity.<xref rid="cit0132" ref-type="bibr">132</xref> Treatment with NB-ER reduced waist circumference by a mean of 7 cm, as opposed to a reduction of 3 cm with the GLP-1R agonist liraglutide.<xref rid="cit0133" ref-type="bibr">133</xref> Thus, among emerging treatments, NB-ER appears to be the most promising to help people quit smoking without gaining weight. Consistent with these findings, the Association for the Study of Obesity on the Island of Ireland recommends NB-ER as the first choice of treatment for patients with obesity who smoke.<xref rid="cit0134" ref-type="bibr">134</xref></p></sec></sec><sec id="s0004"><title>Clinical Recommendations</title><p>Providers should consider treatments to attenuate or prevent post-cessation weight gain for patients who want to quit smoking and (1) have obesity or a BMI &gt;27 with an obesity-associated complication; (2) have a history of significant post-cessation weight gain; or (3) are at risk of not quitting or relapse back to smoking due to weight gain.<xref rid="cit0135" ref-type="bibr">135</xref>,<xref rid="cit0136" ref-type="bibr">136</xref></p><sec id="s0004-s2001"><title>Recommendations for Co-Occurring Obesity and Smoking Cessation</title><p>Currently, obesity treatment guidelines recommend pharmacologic treatment as part of a multifactorial approach to obesity management, along with medical nutrition, physical activity, and, in some cases, metabolic (or bariatric) surgery.<xref rid="cit0137" ref-type="bibr">137&#8211;141</xref> The American Association of Clinical Endocrinologists recommends the use of antiobesity medications in people with progressive weight gain, and the American Association of Clinical Endocrinologists, the Endocrine Society, and Obesity Canada all recommend antiobesity medication for patients with a BMI &#8805;27 with obesity-related complications, such as type 2 diabetes, cardiovascular disease, or metabolic syndrome.<xref rid="cit0137" ref-type="bibr">137</xref> Although specific US guidance on choosing a pharmacotherapy to treat co-occurring obesity and smoking cessation is limited, the Association for the Study of Obesity on the Island of Ireland recommends the use of NB-ER in patients who smoke and have obesity.<xref rid="cit0134" ref-type="bibr">134</xref></p><p>Guidelines for treating each condition highlight multifactorial approaches to treatment. In addition to pharmacotherapy for both conditions, lifestyle modifications, such as increased physical activity and medical nutrition for obesity and behavioral counseling and mindfulness for smoking cessation, should be considered.<xref rid="cit0129" ref-type="bibr">129</xref>,<xref rid="cit0138" ref-type="bibr">138</xref>,<xref rid="cit0139" ref-type="bibr">139</xref>,<xref rid="cit0142" ref-type="bibr">142</xref>,<xref rid="cit0143" ref-type="bibr">143</xref> Primary care professionals should discuss the treatment options with patients, considering their individual goals for weight management, their prior experiences with post-cessation weight gain, and their expectations regarding treatment route and side effects. Moreover, clinicians should consider simultaneously continuing or starting antiobesity medications with smoking cessation medications to mitigate the negative impacts of both conditions on patient health.</p></sec><sec id="s0004-s2002"><title>Recommendations for Post-Cessation Weight Gain</title><p>As weight gain is a major barrier to smoking cessation and a driver of relapse,<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0022" ref-type="bibr">22</xref> there is a clear need for pharmacotherapies to manage post-cessation weight gain. Unfortunately, guidance on treating post-cessation weight gain is limited. Currently, the most effective FDA-approved pharmacotherapy for smoking cessation among those concerned about weight gain is bupropion,<xref rid="cit0129" ref-type="bibr">129</xref> though treatment effects are modest.<xref rid="cit0027" ref-type="bibr">27</xref> The most promising emergent treatment for smoking cessation and prevention of post-cessation weight gain appears to be NB-ER.<xref rid="cit0132" ref-type="bibr">132</xref> Primary care professionals should discuss the treatment options for smoking cessation with patients, considering the impact of each medication on post-cessation weight gain and the concerns patients have regarding weight gain. For patients with concerns about weight gain, primary care professionals should consider treatment options, regardless of BMI, to improve the likelihood of successful smoking cessation and prolonged abstinence.</p></sec></sec><sec id="s0005"><title>Conclusions</title><p>Weight gain after smoking cessation presents a substantial barrier to stopping smoking and to sustained smoking abstinence around the world. Weight gain after smoking cessation is critically important for people with BMI-based or central obesity, who may develop comorbidities with additional weight gain. Similarly, post-cessation weight gain is also important when treating people without obesity who may relapse back to smoking after significant post-cessation weight gain. The drivers of smoking and obesity share neurobiologic mechanisms in neuroendocrine and mesolimbic systems, suggesting the potential of pharmacologic treatments that target these shared mechanisms. Although existing smoking cessation pharmacotherapies have only modest effects on post-cessation weight gain, international guidelines highlight that existing obesity treatments, such as NB-ER, may have promise as treatments for post-cessation weight gain.</p></sec></body><back><ack><title>Acknowledgments</title><p>Medical writing and editorial support were provided by Breanne E. Pirino, PhD, of Red Nucleus, and were funded by Currax Pharmaceuticals, LLC.</p></ack><sec id="s0006"><title>Author Contributions</title><p>All authors made a significant contribution to this work, including the conception of the work and interpretation of findings; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</p></sec><sec sec-type="COI-statement" id="s0007"><title>Disclosure</title><p>AG reports receiving royalties from Springer and Amazon; consulting fees from Boehringer Ingelheim, Currax Pharmaceuticals, LLC, Lilly, Novo Nordisk, and Weight Watchers; and honoraria from Acella Pharmaceuticals, Currax Pharmaceuticals, LLC, Lilly, and Novo Nordisk. JMD reports receiving consulting fees from Currax Pharmaceuticals, LLC. The authors report no other conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>VanFrank</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Malarcher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cornelius</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Schecter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jamal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tynan</surname><given-names>M</given-names></string-name>. <article-title>Adult smoking cessation: United States, 2022</article-title>. <source><italic toggle="yes">MMWR Morb Mortal Wkly Rep</italic></source>. <year>2024</year>;<volume>73</volume>(<issue>29</issue>):<fpage>633</fpage>&#8211;<lpage>641</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7329a1</pub-id><pub-id pub-id-type="pmid">39052529</pub-id><pub-id pub-id-type="pmcid">PMC11290909</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>WHO global report on trends in prevalence of tobacco use 2000-2030</article-title>. <year>2024</year>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/9789240088283" ext-link-type="uri">https://www.who.int/publications/i/item/9789240088283</ext-link>. <date-in-citation>Accessed <month>March</month><day>31</day>, 2025</date-in-citation>.</mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Aubin</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Farley</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lycett</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lahmek</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Aveyard</surname><given-names>P</given-names></string-name>. <article-title>Weight gain in smokers after quitting cigarettes: meta-analysis</article-title>. <source><italic toggle="yes">Br Med J</italic></source>. <year>2012</year>;<volume>345</volume>:<fpage>e4439</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.e4439</pub-id><pub-id pub-id-type="pmid">22782848</pub-id><pub-id pub-id-type="pmcid">PMC3393785</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ellison-Barnes</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yeh</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Pollack</surname><given-names>CE</given-names></string-name>, et al. <article-title>Weighing cessation: rising adiposity of current smokers in NHANES</article-title>. <source><italic toggle="yes">Prev Med</italic></source>. <year>2023</year>;<volume>175</volume>:<fpage>107713</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ypmed.2023.107713</pub-id><pub-id pub-id-type="pmid">37758125</pub-id><pub-id pub-id-type="pmcid">PMC10791148</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>Obesity and overweight</article-title>. <comment>Updated March 1, 2024, Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight</ext-link>. <date-in-citation>Accessed <month>June</month><day>21</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Patel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kaufman</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hunt</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Nebeling</surname><given-names>L</given-names></string-name>. <article-title>Understanding the relationship of cigarette smoking trajectories through adolescence and weight status in young adulthood in the United States</article-title>. <source><italic toggle="yes">J Adolesc Health</italic></source>. <year>2017</year>;<volume>61</volume>(<issue>2</issue>):<fpage>163</fpage>&#8211;<lpage>170</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jadohealth.2017.02.005</pub-id><pub-id pub-id-type="pmid">28431973</pub-id><pub-id pub-id-type="pmcid">PMC5522787</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Munafo</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Tilling</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ben-Shlomo</surname><given-names>Y</given-names></string-name>. <article-title>Smoking status and body mass index: a longitudinal study</article-title>. <source><italic toggle="yes">Nicotine Tob Res</italic></source>. <year>2009</year>;<volume>11</volume>(<issue>6</issue>):<fpage>765</fpage>&#8211;<lpage>771</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ntr/ntp062</pub-id><pub-id pub-id-type="pmid">19443785</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Plurphanswat</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rodu</surname><given-names>B</given-names></string-name>. <article-title>The association of smoking and demographic characteristics on body mass index and obesity among adults in the U.S. 1999-2012</article-title>. <source><italic toggle="yes">BMC Obes</italic></source>. <year>2014</year>;<volume>1</volume>:<fpage>18</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40608-014-0018-0</pub-id><pub-id pub-id-type="pmid">26217505</pub-id><pub-id pub-id-type="pmcid">PMC4510893</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Williamson</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Madans</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Anda</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Kleinman</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Giovino</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Byers</surname><given-names>T</given-names></string-name>. <article-title>Smoking cessation and severity of weight gain in a national cohort</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>1991</year>;<volume>324</volume>(<issue>11</issue>):<fpage>739</fpage>&#8211;<lpage>745</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM199103143241106</pub-id><pub-id pub-id-type="pmid">1997840</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kruger</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ham</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Prohaska</surname><given-names>TR</given-names></string-name>. <article-title>Behavioral risk factors associated with overweight and obesity among older adults: the 2005 National Health Interview Survey</article-title>. <source><italic toggle="yes">Prev Chronic Dis</italic></source>. <year>2009</year>;<volume>6</volume>(<issue>1</issue>):<fpage>A14</fpage>.<pub-id pub-id-type="pmid">19080020</pub-id><pub-id pub-id-type="pmcid">PMC2644612</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tian</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Venn</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Otahal</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gall</surname><given-names>S</given-names></string-name>. <article-title>The association between quitting smoking and weight gain: a systemic review and meta-analysis of prospective cohort studies</article-title>. <source><italic toggle="yes">Obes Rev</italic></source>. <year>2016</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1014</fpage>. doi:<pub-id pub-id-type="doi">10.1111/obr.12448</pub-id><pub-id pub-id-type="pmid">27612637</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Krotter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Garcia-Perez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Aonso-Diego</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Garcia-Fernandez</surname><given-names>G</given-names></string-name>. <article-title>Body weight change during a smoking cessation intervention for individuals with overweight or obesity</article-title>. <source><italic toggle="yes">Eat Behav</italic></source>. <year>2024</year>;<volume>53</volume>:<fpage>101882</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eatbeh.2024.101882</pub-id><pub-id pub-id-type="pmid">38723487</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ninomiya</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kawasoe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kubozono</surname><given-names>T</given-names></string-name>, et al. <article-title>Association between weight gain following smoking cessation and development of hypertension in the future</article-title>. <source><italic toggle="yes">Hypertens Res</italic></source>. <year>2024</year>;<volume>47</volume>(<issue>5</issue>):<fpage>1167</fpage>&#8211;<lpage>1174</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41440-023-01549-8</pub-id><pub-id pub-id-type="pmid">38182903</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Lou</surname><given-names>H</given-names></string-name>. <article-title>Smoking cessation, weight gain, and risk for type 2 diabetes: a prospective study</article-title>. <source><italic toggle="yes">Int J Public Health</italic></source>. <year>2022</year>;<volume>67</volume>:<fpage>1604654</fpage>. doi:<pub-id pub-id-type="doi">10.3389/ijph.2022.1604654</pub-id><pub-id pub-id-type="pmid">35496941</pub-id><pub-id pub-id-type="pmcid">PMC9046538</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bosomworth</surname><given-names>NJ</given-names></string-name>. <article-title>Normal-weight central obesity: unique hazard of the toxic waist</article-title>. <source><italic toggle="yes">Can Fam Physician</italic></source>. <year>2019</year>;<volume>65</volume>(<issue>6</issue>):<fpage>399</fpage>&#8211;<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1787/health_glance-2017-en</pub-id><pub-id pub-id-type="pmid">31189627</pub-id><pub-id pub-id-type="pmcid">PMC6738397</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Franek</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pais</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Basile</surname><given-names>J</given-names></string-name>, et al. <article-title>General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial</article-title>. <source><italic toggle="yes">Cardiovasc Diabetol</italic></source>. <year>2023</year>;<volume>22</volume>(<issue>1</issue>):<fpage>52</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12933-023-01757-z</pub-id><pub-id pub-id-type="pmid">36899386</pub-id><pub-id pub-id-type="pmcid">PMC9999507</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kim</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Yoo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Oh</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>HC</given-names></string-name>. <article-title>Associations of smoking with overall obesity, and central obesity: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2013)</article-title>. <source><italic toggle="yes">Epidemiol Health</italic></source>. <year>2016</year>;<volume>38</volume>:<fpage>e2016020</fpage>. doi:<pub-id pub-id-type="doi">10.4178/epih.e2016020</pub-id><pub-id pub-id-type="pmid">27221478</pub-id><pub-id pub-id-type="pmcid">PMC4967909</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Suutari-Jaasko</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ylitalo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ronkaine</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Huikuri</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kesaniemi</surname><given-names>YA</given-names></string-name>, <string-name name-style="western"><surname>Ukkola</surname><given-names>OH</given-names></string-name>. <article-title>Smoking cessation and obesity-related morbidities and mortality in a 20-year follow-up study</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2022</year>;<volume>17</volume>(<issue>12</issue>):<fpage>e0279443</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0279443</pub-id><pub-id pub-id-type="pmid">36576905</pub-id><pub-id pub-id-type="pmcid">PMC9797072</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tuovinen</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Saarni</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Kinnunen</surname><given-names>TH</given-names></string-name>, et al. <article-title>Weight concerns as a predictor of smoking cessation according to nicotine dependence: a population-based study</article-title>. <source><italic toggle="yes">Nordisk Alkohol Nark</italic></source>. <year>2018</year>;<volume>35</volume>(<issue>5</issue>):<fpage>344</fpage>&#8211;<lpage>356</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1455072518800217</pub-id><pub-id pub-id-type="pmid">32934537</pub-id><pub-id pub-id-type="pmcid">PMC7434149</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kuo</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>CY</given-names></string-name>, et al. <article-title>Body-weight gain in women during smoking cessation is a sex-specific predictor of 6-month abstinence: a retrospective cohort study</article-title>. <source><italic toggle="yes">Front Public Health</italic></source>. <year>2022</year>;<volume>10</volume>:<fpage>872220</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpubh.2022.872220</pub-id><pub-id pub-id-type="pmid">35646773</pub-id><pub-id pub-id-type="pmcid">PMC9139838</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Norregaard</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tonnesen</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Petersen</surname><given-names>L</given-names></string-name>. <article-title>Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches</article-title>. <source><italic toggle="yes">Prev Med</italic></source>. <year>1993</year>;<volume>22</volume>(<issue>2</issue>):<fpage>261</fpage>&#8211;<lpage>271</lpage>. doi:<pub-id pub-id-type="doi">10.1006/pmed.1993.1021</pub-id><pub-id pub-id-type="pmid">8483863</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Borrelli</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Niaura</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hitsman</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Papandonatos</surname><given-names>G</given-names></string-name>. <article-title>Influences of gender and weight gain on short-term relapse to smoking in a cessation trial</article-title>. <source><italic toggle="yes">J Consult Clin Psychol</italic></source>. <year>2001</year>;<volume>69</volume>(<issue>3</issue>):<fpage>511</fpage>&#8211;<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1037//0022-006x.69.3.511</pub-id><pub-id pub-id-type="pmid">11495180</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pomerleau</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Kurth</surname><given-names>CL</given-names></string-name>. <article-title>Willingness of female smokers to tolerate postcessation weight gain</article-title>. <source><italic toggle="yes">J Subst Abuse</italic></source>. <year>1996</year>;<volume>8</volume>(<issue>3</issue>):<fpage>371</fpage>&#8211;<lpage>378</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0899-3289(96)90215-1</pub-id><pub-id pub-id-type="pmid">8934441</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Garcia-Fernandez</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Krotter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gonzalez-Roz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Garcia-Perez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Secades-Villa</surname><given-names>R</given-names></string-name>. <article-title>Effectiveness of including weight management in smoking cessation treatments: a meta-analysis of behavioral interventions</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2023</year>;<volume>140</volume>:<fpage>107606</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2023.107606</pub-id><pub-id pub-id-type="pmid">36642013</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Duan</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>C</given-names></string-name>. <article-title>Varenicline is associated with a modest limitation in weight gain in smokers after smoking cessation: a meta-analysis</article-title>. <source><italic toggle="yes">J Public Health (Oxf)</italic></source>. <year>2018</year>;<volume>40</volume>(<issue>2</issue>):<fpage>e126</fpage>&#8211;<lpage>e132</lpage>. doi:<pub-id pub-id-type="doi">10.1093/pubmed/fdx056</pub-id><pub-id pub-id-type="pmid">28505296</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dale</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Schroeder</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Wolter</surname><given-names>TD</given-names></string-name>, <string-name name-style="western"><surname>Croghan</surname><given-names>IT</given-names></string-name>, <string-name name-style="western"><surname>Hurt</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Offord</surname><given-names>KP</given-names></string-name>. <article-title>Weight change after smoking cessation using variable doses of transdermal nicotine replacement</article-title>. <source><italic toggle="yes">J Gen Intern Med</italic></source>. <year>1998</year>;<volume>13</volume>(<issue>1</issue>):<fpage>9</fpage>&#8211;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1525-1497.1998.00002.x</pub-id><pub-id pub-id-type="pmid">9462489</pub-id><pub-id pub-id-type="pmcid">PMC1496892</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>ML</given-names></string-name>, et al. <article-title>Comparative effectiveness of smoking cessation medications to attenuate weight gain following cessation</article-title>. <source><italic toggle="yes">Subst Use Misuse</italic></source>. <year>2016</year>;<volume>51</volume>(<issue>5</issue>):<fpage>586</fpage>&#8211;<lpage>597</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10826084.2015.1126744</pub-id><pub-id pub-id-type="pmid">27007975</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Breese</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Marks</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Logel</surname><given-names>J</given-names></string-name>, et al. <article-title>Effect of smoking history on [3H]nicotine binding in human postmortem brain</article-title>. <source><italic toggle="yes">J Pharmacol Exp Ther</italic></source>. <year>1997</year>;<volume>282</volume>(<issue>1</issue>):<fpage>7</fpage>&#8211;<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0022-3565(24)36798-9</pub-id><pub-id pub-id-type="pmid">9223534</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Staley</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Krishnan-Sarin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cosgrove</surname><given-names>KP</given-names></string-name>, et al. <article-title>Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2006</year>;<volume>26</volume>(<issue>34</issue>):<fpage>8707</fpage>&#8211;<lpage>8714</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0546-06.2006</pub-id><pub-id pub-id-type="pmid">16928859</pub-id><pub-id pub-id-type="pmcid">PMC6674379</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>de Weijer</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>van de Giessen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>van Amelsvoort</surname><given-names>TA</given-names></string-name>, et al. <article-title>Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects</article-title>. <source><italic toggle="yes">EJNMMI Res</italic></source>. <year>2011</year>;<volume>1</volume>(<issue>1</issue>):<fpage>37</fpage>. doi:<pub-id pub-id-type="doi">10.1186/2191-219X-1-37</pub-id><pub-id pub-id-type="pmid">22214469</pub-id><pub-id pub-id-type="pmcid">PMC3265412</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wang</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Logan</surname><given-names>J</given-names></string-name>, et al. <article-title>Brain dopamine and obesity</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2001</year>;<volume>357</volume>(<issue>9253</issue>):<fpage>354</fpage>&#8211;<lpage>357</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0140-6736(00)03643-6</pub-id><pub-id pub-id-type="pmid">11210998</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mineur</surname><given-names>YS</given-names></string-name>, <string-name name-style="western"><surname>Abizaid</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rao</surname><given-names>Y</given-names></string-name>, et al. <article-title>Nicotine decreases food intake through activation of POMC neurons</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2011</year>;<volume>332</volume>(<issue>6035</issue>):<fpage>1330</fpage>&#8211;<lpage>1332</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1201889</pub-id><pub-id pub-id-type="pmid">21659607</pub-id><pub-id pub-id-type="pmcid">PMC3113664</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Malik</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McGlone</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bedrossian</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Dagher</surname><given-names>A</given-names></string-name>. <article-title>Ghrelin modulates brain activity in areas that control appetitive behavior</article-title>. <source><italic toggle="yes">Cell Metab</italic></source>. <year>2008</year>;<volume>7</volume>(<issue>5</issue>):<fpage>400</fpage>&#8211;<lpage>409</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2008.03.007</pub-id><pub-id pub-id-type="pmid">18460331</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kallo</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Omrani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Meye</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Liposits</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Adan</surname><given-names>RAH</given-names></string-name>. <article-title>Characterization of orexin input to dopamine neurons of the ventral tegmental area projecting to the medial prefrontal cortex and shell of nucleus accumbens</article-title>. <source><italic toggle="yes">Brain Struct Funct</italic></source>. <year>2022</year>;<volume>227</volume>(<issue>3</issue>):<fpage>1083</fpage>&#8211;<lpage>1098</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00429-021-02449-8</pub-id><pub-id pub-id-type="pmid">35029758</pub-id><pub-id pub-id-type="pmcid">PMC8930802</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Farooqi</surname><given-names>IS</given-names></string-name>, <string-name name-style="western"><surname>Bullmore</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Keogh</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gillard</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Rahilly</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fletcher</surname><given-names>PC</given-names></string-name>. <article-title>Leptin regulates striatal regions and human eating behavior</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2007</year>;<volume>317</volume>(<issue>5843</issue>):<fpage>1355</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1144599</pub-id><pub-id pub-id-type="pmid">17690262</pub-id><pub-id pub-id-type="pmcid">PMC3838941</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Omrani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>de Vrind</surname><given-names>VAJ</given-names></string-name>, <string-name name-style="western"><surname>Lodder</surname><given-names>B</given-names></string-name>, et al. <article-title>Identification of novel neurocircuitry through which leptin targets multiple inputs to the dopamine system to reduce food reward seeking</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2021</year>;<volume>90</volume>(<issue>12</issue>):<fpage>843</fpage>&#8211;<lpage>852</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2021.02.017</pub-id><pub-id pub-id-type="pmid">33867112</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ferreira-Hermosillo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>de Miguel Ibanez</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Perez-Dionisio</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Villalobos-Mata</surname><given-names>KA</given-names></string-name>. <article-title>Obesity as a neuroendocrine disorder</article-title>. <source><italic toggle="yes">Arch Med Res</italic></source>. <year>2023</year>;<volume>54</volume>(<issue>8</issue>):<fpage>102896</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arcmed.2023.102896</pub-id><pub-id pub-id-type="pmid">37945442</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wharton</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>DCW</given-names></string-name>, <string-name name-style="western"><surname>Vallis</surname><given-names>M</given-names></string-name>, et al. <article-title>Obesity in adults: a clinical practice guideline</article-title>. <source><italic toggle="yes">CMAJ</italic></source>. <year>2020</year>;<volume>192</volume>(<issue>31</issue>):<fpage>E875</fpage>&#8211;<lpage>E891</lpage>. doi:<pub-id pub-id-type="doi">10.1503/cmaj.191707</pub-id><pub-id pub-id-type="pmid">32753461</pub-id><pub-id pub-id-type="pmcid">PMC7828878</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dodd</surname><given-names>GT</given-names></string-name>, <string-name name-style="western"><surname>Michael</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Lee-Young</surname><given-names>RS</given-names></string-name>, et al. <article-title>Insulin regulates POMC neuronal plasticity to control glucose metabolism</article-title>. <source><italic toggle="yes">Elife</italic></source>. <year>2018</year>;<volume>7</volume>:<fpage>e38704</fpage>. doi:<pub-id pub-id-type="doi">10.7554/eLife.38704</pub-id><pub-id pub-id-type="pmid">30230471</pub-id><pub-id pub-id-type="pmcid">PMC6170188</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Campos</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Port</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Acosta</surname><given-names>A</given-names></string-name>. <article-title>Integrative hedonic and homeostatic food intake regulation by the central nervous system: insights from neuroimaging</article-title>. <source><italic toggle="yes">Brain Sci</italic></source>. <year>2022</year>;<volume>12</volume>(<issue>4</issue>):<fpage>431</fpage>. doi:<pub-id pub-id-type="doi">10.3390/brainsci12040431</pub-id><pub-id pub-id-type="pmid">35447963</pub-id><pub-id pub-id-type="pmcid">PMC9032173</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jais</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bruning</surname><given-names>JC</given-names></string-name>. <article-title>Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus</article-title>. <source><italic toggle="yes">Endocr Rev</italic></source>. <year>2022</year>;<volume>43</volume>(<issue>2</issue>):<fpage>314</fpage>&#8211;<lpage>328</lpage>. doi:<pub-id pub-id-type="doi">10.1210/endrev/bnab025</pub-id><pub-id pub-id-type="pmid">34490882</pub-id><pub-id pub-id-type="pmcid">PMC8905335</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jin</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>X</given-names></string-name>. <article-title>Neuropeptides modulate feeding via the dopamine reward pathway</article-title>. <source><italic toggle="yes">Neurochem Res</italic></source>. <year>2023</year>;<volume>48</volume>(<issue>9</issue>):<fpage>2622</fpage>&#8211;<lpage>2643</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11064-023-03954-4</pub-id><pub-id pub-id-type="pmid">37233918</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mangieri</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>, et al. <article-title>A neural basis for antagonistic control of feeding and compulsive behaviors</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>52</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-017-02534-9</pub-id><pub-id pub-id-type="pmid">29302029</pub-id><pub-id pub-id-type="pmcid">PMC5754347</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yohn</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Galbraith</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Calipari</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Conn</surname><given-names>PJ</given-names></string-name>. <article-title>Shared behavioral and neurocircuitry disruptions in drug addiction, obesity, and binge eating disorder: focus on group I mGluRs in the mesolimbic dopamine pathway</article-title>. <source><italic toggle="yes">ACS Chem Neurosci</italic></source>. <year>2019</year>;<volume>10</volume>(<issue>5</issue>):<fpage>2125</fpage>&#8211;<lpage>2143</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.8b00601</pub-id><pub-id pub-id-type="pmid">30933466</pub-id><pub-id pub-id-type="pmcid">PMC7898461</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Alhadeff</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Goldstein</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Klima</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Vargas</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Betley</surname><given-names>JN</given-names></string-name>. <article-title>Natural and drug rewards engage distinct pathways that converge on coordinated hypothalamic and reward circuits</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>2019</year>;<volume>103</volume>(<issue>5</issue>):<fpage>891</fpage>&#8211;<lpage>908e6</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.050</pub-id><pub-id pub-id-type="pmid">31277924</pub-id><pub-id pub-id-type="pmcid">PMC6728176</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Koob</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Le Moal</surname><given-names>M</given-names></string-name>. <article-title>Addiction and the brain antireward system</article-title>. <source><italic toggle="yes">Annu Rev Psychol</italic></source>. <year>2008</year>;<volume>59</volume>:<fpage>29</fpage>&#8211;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.psych.59.103006.093548</pub-id><pub-id pub-id-type="pmid">18154498</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tan</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Browne</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Nobauer</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vaziri</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Nestler</surname><given-names>EJ</given-names></string-name>. <article-title>Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2024</year>;<volume>384</volume>(<issue>6693</issue>). doi:<pub-id pub-id-type="doi">10.1126/science.adk6742</pub-id><pub-id pub-id-type="pmcid">PMC11077477</pub-id><pub-id pub-id-type="pmid">38669575</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Xu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>F</given-names></string-name>. <article-title>The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia</article-title>. <source><italic toggle="yes">Transl Psychiatry</italic></source>. <year>2022</year>;<volume>12</volume>(<issue>1</issue>):<fpage>464</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41398-022-02233-0</pub-id><pub-id pub-id-type="pmid">36344514</pub-id><pub-id pub-id-type="pmcid">PMC9640700</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Baik</surname><given-names>JH</given-names></string-name>. <article-title>Dopaminergic control of the feeding circuit</article-title>. <source><italic toggle="yes">Endocrinol Metab (Seoul)</italic></source>. <year>2021</year>;<volume>36</volume>(<issue>2</issue>):<fpage>229</fpage>&#8211;<lpage>239</lpage>. doi:<pub-id pub-id-type="doi">10.3803/EnM.2021.979</pub-id><pub-id pub-id-type="pmid">33820393</pub-id><pub-id pub-id-type="pmcid">PMC8090468</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Roh</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>KM</given-names></string-name>. <article-title>Hormonal gut-brain signaling for the treatment of obesity</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2023</year>;<volume>24</volume>(<issue>4</issue>):<fpage>3384</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms24043384</pub-id><pub-id pub-id-type="pmid">36834794</pub-id><pub-id pub-id-type="pmcid">PMC9959457</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Souza</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Solon</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Nascimento</surname><given-names>LF</given-names></string-name>, et al. <article-title>Defective regulation of POMC precedes hypothalamic inflammation in diet-induced obesity</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>29290</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep29290</pub-id><pub-id pub-id-type="pmid">27373214</pub-id><pub-id pub-id-type="pmcid">PMC4931679</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>De Solis</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Del Rio-Martin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Radermacher</surname><given-names>J</given-names></string-name>, et al. <article-title>Reciprocal activity of AgRP and POMC neurons governs coordinated control of feeding and metabolism</article-title>. <source><italic toggle="yes">Nat Metab</italic></source>. <year>2024</year>;<volume>6</volume>(<issue>3</issue>):<fpage>473</fpage>&#8211;<lpage>493</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s42255-024-00987-z</pub-id><pub-id pub-id-type="pmid">38378998</pub-id><pub-id pub-id-type="pmcid">PMC10963273</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Garfield</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Madara</surname><given-names>JC</given-names></string-name>, et al. <article-title>A neural basis for melanocortin-4 receptor-regulated appetite</article-title>. <source><italic toggle="yes">Nat Neurosci</italic></source>. <year>2015</year>;<volume>18</volume>(<issue>6</issue>):<fpage>863</fpage>&#8211;<lpage>871</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4011</pub-id><pub-id pub-id-type="pmid">25915476</pub-id><pub-id pub-id-type="pmcid">PMC4446192</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></string-name>, et al. <article-title>Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons</article-title>. <source><italic toggle="yes">Front Neuroanat</italic></source>. <year>2015</year>;<volume>9</volume>:<fpage>40</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnana.2015.00040</pub-id><pub-id pub-id-type="pmid">25870542</pub-id><pub-id pub-id-type="pmcid">PMC4375998</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Contreras-Rodriguez</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Vilar-Lopez</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>ZB</given-names></string-name>, <string-name name-style="western"><surname>Navas</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Soriano-Mas</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Verdejo-Garcia</surname><given-names>A</given-names></string-name>. <article-title>Altered cross-talk between the hypothalamus and non-homeostatic regions linked to obesity and difficulty to lose weight</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>9951</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-09874-y</pub-id><pub-id pub-id-type="pmid">28855582</pub-id><pub-id pub-id-type="pmcid">PMC5577266</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Norgren</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hajnal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mungarndee</surname><given-names>SS</given-names></string-name>. <article-title>Gustatory reward and the nucleus accumbens</article-title>. <source><italic toggle="yes">Physiol Behav</italic></source>. <year>2006</year>;<volume>89</volume>(<issue>4</issue>):<fpage>531</fpage>&#8211;<lpage>535</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.physbeh.2006.05.024</pub-id><pub-id pub-id-type="pmid">16822531</pub-id><pub-id pub-id-type="pmcid">PMC3114426</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dunigan</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Roseberry</surname><given-names>AG</given-names></string-name>. <article-title>Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards</article-title>. <source><italic toggle="yes">Addict Neurosci</italic></source>. <year>2022</year>;<volume>2</volume>:<fpage>100011</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addicn.2022.100011</pub-id><pub-id pub-id-type="pmid">37220637</pub-id><pub-id pub-id-type="pmcid">PMC10201992</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dunigan</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Olson</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Roseberry</surname><given-names>AG</given-names></string-name>. <article-title>VTA MC3R neurons control feeding in an activity- and sex-dependent manner in mice</article-title>. <source><italic toggle="yes">Neuropharmacology</italic></source>. <year>2021</year>;<volume>197</volume>:<fpage>108746</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2021.108746</pub-id><pub-id pub-id-type="pmid">34371079</pub-id><pub-id pub-id-type="pmcid">PMC8478831</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brown</surname><given-names>SSG</given-names></string-name>, <string-name name-style="western"><surname>Westwater</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Seidlitz</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ziauddeen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fletcher</surname><given-names>PC</given-names></string-name>. <article-title>Hypothalamic volume is associated with body mass index</article-title>. <source><italic toggle="yes">Neuroimage Clin</italic></source>. <year>2023</year>;<volume>39</volume>:<fpage>103478</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2023.103478</pub-id><pub-id pub-id-type="pmid">37558541</pub-id><pub-id pub-id-type="pmcid">PMC10509524</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Thomas</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Beyer</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lewe</surname><given-names>G</given-names></string-name>, et al. <article-title>Higher body mass index is linked to altered hypothalamic microstructure</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>17373</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-53578-4</pub-id><pub-id pub-id-type="pmid">31758009</pub-id><pub-id pub-id-type="pmcid">PMC6874651</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Venkatasubramanian</surname><given-names>PN</given-names></string-name>, <string-name name-style="western"><surname>Keni</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gastfield</surname><given-names>R</given-names></string-name>, et al. <article-title>Diffusion tensor imaging detects acute and subacute changes in corpus callosum in blast-induced traumatic brain injury</article-title>. <source><italic toggle="yes">ASN Neuro</italic></source>. <year>2020</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1759091420922929</fpage>. doi:<pub-id pub-id-type="doi">10.1177/1759091420922929</pub-id><pub-id pub-id-type="pmid">32403948</pub-id><pub-id pub-id-type="pmcid">PMC7238783</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kullmann</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Abbas</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Machann</surname><given-names>J</given-names></string-name>, et al. <article-title>Investigating obesity-associated brain inflammation using quantitative water content mapping</article-title>. <source><italic toggle="yes">J Neuroendocrinol</italic></source>. <year>2020</year>;<volume>32</volume>(<issue>12</issue>):<fpage>e12907</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jne.12907</pub-id><pub-id pub-id-type="pmid">33025697</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Simmons</surname><given-names>WK</given-names></string-name>, <string-name name-style="western"><surname>Herscovitch</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>KD</given-names></string-name>. <article-title>Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior</article-title>. <source><italic toggle="yes">Mol Psychiatry</italic></source>. <year>2014</year>;<volume>19</volume>(<issue>10</issue>):<fpage>1078</fpage>&#8211;<lpage>1084</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2014.102</pub-id><pub-id pub-id-type="pmid">25199919</pub-id><pub-id pub-id-type="pmcid">PMC4189966</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ribeiro</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Maia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cotovio</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Oliveira</surname><given-names>FPM</given-names></string-name>, <string-name name-style="western"><surname>Costa</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Oliveira-Maia</surname><given-names>AJ</given-names></string-name>. <article-title>Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2023</year>;<volume>13</volume>(<issue>1</issue>):<fpage>4959</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-023-31250-2</pub-id><pub-id pub-id-type="pmid">36973321</pub-id><pub-id pub-id-type="pmcid">PMC10042861</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Weir</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Jan</surname><given-names>A</given-names></string-name>. <source><italic toggle="yes">BMI Classification Percentile and Cut off Points</italic></source>. <publisher-name>StatPearls. StatPearls Publishing</publisher-name>; <year>2024</year>.<pub-id pub-id-type="pmid">31082114</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Byberg</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Futtrup</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Andreassen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Krogh</surname><given-names>J</given-names></string-name>. <article-title>Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Endocr Connect</italic></source>. <year>2019</year>;<volume>8</volume>(<issue>10</issue>):<fpage>1395</fpage>&#8211;<lpage>1404</lpage>. doi:<pub-id pub-id-type="doi">10.1530/EC-19-0286</pub-id><pub-id pub-id-type="pmid">31518995</pub-id><pub-id pub-id-type="pmcid">PMC6826167</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pontieri</surname><given-names>FE</given-names></string-name>, <string-name name-style="western"><surname>Tanda</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Orzi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Di Chiara</surname><given-names>G</given-names></string-name>. <article-title>Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>1996</year>;<volume>382</volume>(<issue>6588</issue>):<fpage>255</fpage>&#8211;<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.1038/382255a0</pub-id><pub-id pub-id-type="pmid">8717040</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brody</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Mandelkern</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Olmstead</surname><given-names>RE</given-names></string-name>, et al. <article-title>Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette</article-title>. <source><italic toggle="yes">Neuropsychopharmacology</italic></source>. <year>2009</year>;<volume>34</volume>(<issue>2</issue>):<fpage>282</fpage>&#8211;<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2008.87</pub-id><pub-id pub-id-type="pmid">18563061</pub-id><pub-id pub-id-type="pmcid">PMC2777990</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>D</given-names></string-name>, et al. <article-title>Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2012</year>;<volume>32</volume>(<issue>36</issue>):<fpage>12366</fpage>&#8211;<lpage>12375</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5411-11.2012</pub-id><pub-id pub-id-type="pmid">22956827</pub-id><pub-id pub-id-type="pmcid">PMC3516404</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Calarco</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>SR</given-names></string-name>, et al. <article-title>Molecular and cellular characterization of nicotinic acetylcholine receptor subtypes in the arcuate nucleus of the mouse hypothalamus</article-title>. <source><italic toggle="yes">Eur J Neurosci</italic></source>. <year>2018</year>;<volume>48</volume>(<issue>1</issue>):<fpage>1600</fpage>&#8211;<lpage>1619</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ejn.13966</pub-id><pub-id pub-id-type="pmcid">PMC6251769</pub-id><pub-id pub-id-type="pmid">29791746</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brody</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Mukhin</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Mamoun</surname><given-names>MS</given-names></string-name>, et al. <article-title>Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial</article-title>. <source><italic toggle="yes">JAMA Psychiatry</italic></source>. <year>2014</year>;<volume>71</volume>(<issue>7</issue>):<fpage>797</fpage>&#8211;<lpage>805</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.138</pub-id><pub-id pub-id-type="pmid">24850280</pub-id><pub-id pub-id-type="pmcid">PMC4634637</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></string-name>. <article-title>Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics</article-title>. <source><italic toggle="yes">Annu Rev Pharmacol Toxicol</italic></source>. <year>2009</year>;<volume>49</volume>:<fpage>57</fpage>&#8211;<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.pharmtox.48.113006.094742</pub-id><pub-id pub-id-type="pmid">18834313</pub-id><pub-id pub-id-type="pmcid">PMC2946180</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fehr</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yakushev</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hohmann</surname><given-names>N</given-names></string-name>, et al. <article-title>Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse</article-title>. <source><italic toggle="yes">Am J Psychiatry</italic></source>. <year>2008</year>;<volume>165</volume>(<issue>4</issue>):<fpage>507</fpage>&#8211;<lpage>514</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2007.07020352</pub-id><pub-id pub-id-type="pmid">18316420</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Robinson</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>M</given-names></string-name>, et al. <article-title>Evaluating the temporal relationships between withdrawal symptoms and smoking relapse</article-title>. <source><italic toggle="yes">Psychol Addict Behav</italic></source>. <year>2019</year>;<volume>33</volume>(<issue>2</issue>):<fpage>105</fpage>&#8211;<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1037/adb0000434</pub-id><pub-id pub-id-type="pmid">30614717</pub-id><pub-id pub-id-type="pmcid">PMC6405298</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yasuno</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ota</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ando</surname><given-names>K</given-names></string-name>, et al. <article-title>Role of ventral striatal dopamine D1 receptor in cigarette craving</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2007</year>;<volume>61</volume>(<issue>11</issue>):<fpage>1252</fpage>&#8211;<lpage>1259</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.06.028</pub-id><pub-id pub-id-type="pmid">16945342</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wills</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kenny</surname><given-names>PJ</given-names></string-name>. <article-title>Addiction-related neuroadaptations following chronic nicotine exposure</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2021</year>;<volume>157</volume>(<issue>5</issue>):<fpage>1652</fpage>&#8211;<lpage>1673</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.15356</pub-id><pub-id pub-id-type="pmid">33742685</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jackson</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Muldoon</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>De Biasi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Damaj</surname><given-names>MI</given-names></string-name>. <article-title>New mechanisms and perspectives in nicotine withdrawal</article-title>. <source><italic toggle="yes">Neuropharmacology</italic></source>. <year>2015</year>;<volume>96</volume>(<issue>Pt B</issue>):<fpage>223</fpage>&#8211;<lpage>234</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.11.009</pub-id><pub-id pub-id-type="pmid">25433149</pub-id><pub-id pub-id-type="pmcid">PMC4444410</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Doyon</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Dani</surname><given-names>JA</given-names></string-name>. <article-title>Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2012</year>;<volume>71</volume>(<issue>3</issue>):<fpage>184</fpage>&#8211;<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2011.07.024</pub-id><pub-id pub-id-type="pmid">21872847</pub-id><pub-id pub-id-type="pmcid">PMC3227792</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Oliver</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Evans</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Addicott</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Potts</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Brandon</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Drobes</surname><given-names>DJ</given-names></string-name>. <article-title>Nicotine withdrawal induces neural deficits in reward processing</article-title>. <source><italic toggle="yes">Nicotine Tob Res</italic></source>. <year>2017</year>;<volume>19</volume>(<issue>6</issue>):<fpage>686</fpage>&#8211;<lpage>693</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ntr/ntx067</pub-id><pub-id pub-id-type="pmid">28371807</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>McCaul</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Wand</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Kuwabara</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dannals</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>X</given-names></string-name>. <article-title>The relationship of varenicline agonism of alpha4beta2 nicotinic acetylcholine receptors and nicotine-induced dopamine release in nicotine-dependent humans</article-title>. <source><italic toggle="yes">Nicotine Tob Res</italic></source>. <year>2020</year>;<volume>22</volume>(<issue>6</issue>):<fpage>892</fpage>&#8211;<lpage>899</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ntr/ntz080</pub-id><pub-id pub-id-type="pmid">31096265</pub-id><pub-id pub-id-type="pmcid">PMC7529151</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Piacentini</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Clinckers</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Meeusen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sarre</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ebinger</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Michotte</surname><given-names>Y</given-names></string-name>. <article-title>Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat</article-title>. <source><italic toggle="yes">J Appl Physiol</italic></source>. <year>2003</year>;<volume>95</volume>(<issue>2</issue>):<fpage>652</fpage>&#8211;<lpage>656</lpage>. doi:<pub-id pub-id-type="doi">10.1152/japplphysiol.01058.2002</pub-id><pub-id pub-id-type="pmid">12692144</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bruijnzeel</surname><given-names>AW</given-names></string-name>. <article-title>Tobacco addiction and the dysregulation of brain stress systems</article-title>. <source><italic toggle="yes">Neurosci Biobehav Rev</italic></source>. <year>2012</year>;<volume>36</volume>(<issue>5</issue>):<fpage>1418</fpage>&#8211;<lpage>1441</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.02.015</pub-id><pub-id pub-id-type="pmid">22405889</pub-id><pub-id pub-id-type="pmcid">PMC3340450</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Haseltine</surname><given-names>KN</given-names></string-name>, <string-name name-style="western"><surname>Robins</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Cohen</surname><given-names>V</given-names></string-name>, et al. <article-title>MON-321 AgRP and food cravings decrease with treatment of Cushing&#8217;s disease</article-title>. <source><italic toggle="yes">J Endocr Soc</italic></source>. <year>2020</year>;<volume>4</volume>(<issue>Suppl 1</issue>):<fpage>MON</fpage>&#8211;<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jendso/bvaa046.1401</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Steculorum</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Ruud</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karakasilioti</surname><given-names>I</given-names></string-name>, et al. <article-title>AgRP neurons control systemic insulin sensitivity via myostatin expression in brown adipose tissue</article-title>. <source><italic toggle="yes">Cell</italic></source>. <year>2016</year>;<volume>165</volume>(<issue>1</issue>):<fpage>125</fpage>&#8211;<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.02.044</pub-id><pub-id pub-id-type="pmid">27015310</pub-id><pub-id pub-id-type="pmcid">PMC5157157</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>W</given-names></string-name>, et al. <article-title>Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo</article-title>. <source><italic toggle="yes">Nat Med</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>4</issue>):<fpage>373</fpage>&#8211;<lpage>382</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3826</pub-id><pub-id pub-id-type="pmid">25799226</pub-id><pub-id pub-id-type="pmcid">PMC4390501</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kullmann</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Valenta</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Wagner</surname><given-names>R</given-names></string-name>, et al. <article-title>Brain insulin sensitivity is linked to adiposity and body fat distribution</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>1841</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-020-15686-y</pub-id><pub-id pub-id-type="pmid">32296068</pub-id><pub-id pub-id-type="pmcid">PMC7160151</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dare</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mackay</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Pell</surname><given-names>JP</given-names></string-name>. <article-title>Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2015</year>;<volume>10</volume>(<issue>4</issue>):<fpage>e0123579</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0123579</pub-id><pub-id pub-id-type="pmid">25886648</pub-id><pub-id pub-id-type="pmcid">PMC4401671</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Driva</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Korkontzelou</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tonstad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tentolouris</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Katsaounou</surname><given-names>P</given-names></string-name>. <article-title>The effect of smoking cessation on body weight and other metabolic parameters with focus on people with type 2 diabetes mellitus</article-title>. <source><italic toggle="yes">Int J Environ Res Public Health</italic></source>. <year>2022</year>;<volume>19</volume>(<issue>20</issue>):<fpage>13222</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph192013222</pub-id><pub-id pub-id-type="pmid">36293800</pub-id><pub-id pub-id-type="pmcid">PMC9603007</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Majuri</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Joutsa</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Johansson</surname><given-names>J</given-names></string-name>, et al. <article-title>Dopamine and opioid neurotransmission in behavioral addictions: a comparative PET study in pathological gambling and binge eating</article-title>. <source><italic toggle="yes">Neuropsychopharmacology</italic></source>. <year>2017</year>;<volume>42</volume>(<issue>5</issue>):<fpage>1169</fpage>&#8211;<lpage>1177</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2016.265</pub-id><pub-id pub-id-type="pmid">27882998</pub-id><pub-id pub-id-type="pmcid">PMC5357051</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Palavra</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Lubomski</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Flood</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Sue</surname><given-names>CM</given-names></string-name>. <article-title>Increased added sugar consumption is common in Parkinson&#8217;s disease</article-title>. <source><italic toggle="yes">Front Nutr</italic></source>. <year>2021</year>;<volume>8</volume>:<fpage>628845</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnut.2021.628845</pub-id><pub-id pub-id-type="pmid">34026805</pub-id><pub-id pub-id-type="pmcid">PMC8138322</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bradley</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>, et al. <article-title>Effect of smoking status on total energy expenditure</article-title>. <source><italic toggle="yes">Nutr Metab (Lond)</italic></source>. <year>2010</year>;<volume>7</volume>(<issue>1</issue>):<fpage>81</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1743-7075-7-81</pub-id><pub-id pub-id-type="pmid">21040542</pub-id><pub-id pub-id-type="pmcid">PMC2989978</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hofstetter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schutz</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jequier</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wahren</surname><given-names>J</given-names></string-name>. <article-title>Increased 24-hour energy expenditure in cigarette smokers</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>1986</year>;<volume>314</volume>(<issue>2</issue>):<fpage>79</fpage>&#8211;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM198601093140204</pub-id><pub-id pub-id-type="pmid">3941694</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Anker</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Raatz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>al&#8217;Absi</surname><given-names>M</given-names></string-name>. <article-title>Tobacco withdrawal increases junk food intake: the role of the endogenous opioid system</article-title>. <source><italic toggle="yes">Drug Alcohol Depend</italic></source>. <year>2021</year>;<volume>225</volume>:<fpage>108819</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108819</pub-id><pub-id pub-id-type="pmid">34182373</pub-id><pub-id pub-id-type="pmcid">PMC8297656</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rodin</surname><given-names>J</given-names></string-name>. <article-title>Weight change following smoking cessation: the role of food intake and exercise</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>1987</year>;<volume>12</volume>(<issue>4</issue>):<fpage>303</fpage>&#8211;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0306-4603(87)90045-1</pub-id><pub-id pub-id-type="pmid">3687515</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="book"><collab>Chantix (varenicline)</collab>. <source><italic toggle="yes">Package insert</italic></source>. <publisher-name>Pfizer</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tonstad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Arons</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rollema</surname><given-names>H</given-names></string-name>, et al. <article-title>Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations</article-title>. <source><italic toggle="yes">Curr Med Res Opin</italic></source>. <year>2020</year>;<volume>36</volume>(<issue>5</issue>):<fpage>713</fpage>&#8211;<lpage>730</lpage>. doi:<pub-id pub-id-type="doi">10.1080/03007995.2020.1729708</pub-id><pub-id pub-id-type="pmid">32050807</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="book"><collab>Zyban (bupropion HCl)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>GSK</publisher-name>; <year>2021</year>.</mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Warner</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Shoaib</surname><given-names>M</given-names></string-name>. <article-title>How does bupropion work as a smoking cessation aid?</article-title><source><italic toggle="yes">Addict Biol</italic></source>. <year>2005</year>;<volume>10</volume>(<issue>3</issue>):<fpage>219</fpage>&#8211;<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13556210500222670</pub-id><pub-id pub-id-type="pmid">16109583</pub-id></mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="book"><collab>Nicotrol NS (nicotine nasal spray)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>Pfizer</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Molyneux</surname><given-names>A</given-names></string-name>. <article-title>Nicotine replacement therapy</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2004</year>;<volume>328</volume>(<issue>7437</issue>):<fpage>454</fpage>&#8211;<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.328.7437.454</pub-id><pub-id pub-id-type="pmid">14976103</pub-id><pub-id pub-id-type="pmcid">PMC344271</pub-id></mixed-citation></ref><ref id="cit0101"><label>101.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cahill</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Stevens</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Perera</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname><given-names>T</given-names></string-name>. <article-title>Pharmacological interventions for smoking cessation: an overview and network meta-analysis</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2013</year>;<volume>2013</volume>(<issue>5</issue>):<fpage>CD009329</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD009329.pub2</pub-id><pub-id pub-id-type="pmid">23728690</pub-id><pub-id pub-id-type="pmcid">PMC8406789</pub-id></mixed-citation></ref><ref id="cit0102"><label>102.</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>The global health observatory: cytisine</article-title>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-tobacco-offerhelp-medication-cytisine-place-available" ext-link-type="uri">https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-tobacco-offerhelp-medication-cytisine-place-available</ext-link>. <date-in-citation>Accessed <month>March</month><day>12</day>, 2025</date-in-citation>.</mixed-citation></ref><ref id="cit0103"><label>103.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rigotti</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Prochaska</surname><given-names>J</given-names></string-name>, et al. <article-title>Cytisinicline for smoking cessation: a randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2023</year>;<volume>330</volume>(<issue>2</issue>):<fpage>152</fpage>&#8211;<lpage>160</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2023.10042</pub-id><pub-id pub-id-type="pmid">37432430</pub-id><pub-id pub-id-type="pmcid">PMC10336611</pub-id></mixed-citation></ref><ref id="cit0104"><label>104.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tronieri</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Wadden</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>O</given-names></string-name>, et al. <article-title>Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial</article-title>. <source><italic toggle="yes">Int J Obes (Lond)</italic></source>. <year>2020</year>;<volume>44</volume>(<issue>2</issue>):<fpage>353</fpage>&#8211;<lpage>361</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41366-019-0348-6</pub-id><pub-id pub-id-type="pmid">30926955</pub-id><pub-id pub-id-type="pmcid">PMC6766432</pub-id></mixed-citation></ref><ref id="cit0105"><label>105.</label><mixed-citation publication-type="book"><collab>Victoza (liraglutide)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>Novo Nordisk</publisher-name>; <year>2017</year>.</mixed-citation></ref><ref id="cit0106"><label>106.</label><mixed-citation publication-type="book"><collab>Zepbound (tirzepatide)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>Eli Lilly</publisher-name>; <year>2023</year>.</mixed-citation></ref><ref id="cit0107"><label>107.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Gabery</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Salinas</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Paulsen</surname><given-names>SJ</given-names></string-name>, et al. <article-title>Semaglutide lowers body weight in rodents via distributed neural pathways</article-title>. <source><italic toggle="yes">JCI Insight</italic></source>. <year>2020</year>;<volume>5</volume>(<issue>6</issue>):<fpage>e133429</fpage>. doi:<pub-id pub-id-type="doi">10.1172/jci.insight.133429</pub-id><pub-id pub-id-type="pmid">32213703</pub-id><pub-id pub-id-type="pmcid">PMC7213778</pub-id></mixed-citation></ref><ref id="cit0108"><label>108.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Huang</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Acosta</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Ghidewon</surname><given-names>MY</given-names></string-name>, et al. <article-title>Dissociable hindbrain GLP1R circuits for satiety and aversion</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2024</year>;<volume>632</volume>(<issue>8025</issue>):<fpage>585</fpage>&#8211;<lpage>593</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-024-07685-6</pub-id><pub-id pub-id-type="pmid">38987598</pub-id></mixed-citation></ref><ref id="cit0109"><label>109.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rhea</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Babin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>P</given-names></string-name>, et al. <article-title>Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer&#8217;s and Parkinson&#8217;s diseases</article-title>. <source><italic toggle="yes">Tissue Barriers</italic></source>. <year>2024</year>;<volume>12</volume>(<issue>4</issue>):<fpage>2292461</fpage>. doi:<pub-id pub-id-type="doi">10.1080/21688370.2023.2292461</pub-id><pub-id pub-id-type="pmid">38095516</pub-id><pub-id pub-id-type="pmcid">PMC11583597</pub-id></mixed-citation></ref><ref id="cit0110"><label>110.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Secher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jelsing</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Baquero</surname><given-names>AF</given-names></string-name>, et al. <article-title>The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss</article-title>. <source><italic toggle="yes">J Clin Invest</italic></source>. <year>2014</year>;<volume>124</volume>(<issue>10</issue>):<fpage>4473</fpage>&#8211;<lpage>4488</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI75276</pub-id><pub-id pub-id-type="pmid">25202980</pub-id><pub-id pub-id-type="pmcid">PMC4215190</pub-id></mixed-citation></ref><ref id="cit0111"><label>111.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Trenson</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Trenson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>van Nes</surname><given-names>F</given-names></string-name>, et al. <article-title>Liraglutide for weight management in the real world: significant weight loss even if the maximal daily dose is not achieved</article-title>. <source><italic toggle="yes">Obes Facts</italic></source>. <year>2022</year>;<volume>15</volume>(<issue>1</issue>):<fpage>83</fpage>&#8211;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000520217</pub-id><pub-id pub-id-type="pmid">34808630</pub-id><pub-id pub-id-type="pmcid">PMC8820228</pub-id></mixed-citation></ref><ref id="cit0112"><label>112.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pi-Sunyer</surname><given-names>X</given-names></string-name>. <article-title>SCALE obesity and prediabetes investigators. Liraglutide in weight management</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2015</year>;<volume>373</volume>(<issue>18</issue>):<fpage>1781</fpage>&#8211;<lpage>1782</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMc1509759</pub-id><pub-id pub-id-type="pmid">26510028</pub-id></mixed-citation></ref><ref id="cit0113"><label>113.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rubino</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Greenway</surname><given-names>FL</given-names></string-name>, <string-name name-style="western"><surname>Khalid</surname><given-names>U</given-names></string-name>, et al. <article-title>Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2022</year>;<volume>327</volume>(<issue>2</issue>):<fpage>138</fpage>&#8211;<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2021.23619</pub-id><pub-id pub-id-type="pmid">35015037</pub-id><pub-id pub-id-type="pmcid">PMC8753508</pub-id></mixed-citation></ref><ref id="cit0114"><label>114.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jastreboff</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Aronne</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Ahmad</surname><given-names>NN</given-names></string-name>, et al. <article-title>Tirzepatide once weekly for the treatment of obesity</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2022</year>;<volume>387</volume>(<issue>3</issue>):<fpage>205</fpage>&#8211;<lpage>216</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2206038</pub-id><pub-id pub-id-type="pmid">35658024</pub-id></mixed-citation></ref><ref id="cit0115"><label>115.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>St&#259;cescu</surname><given-names>&#536;</given-names></string-name>, <string-name name-style="western"><surname>Hancu</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Podar</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Todea</surname><given-names>&#536;</given-names></string-name>, <string-name name-style="western"><surname>Tero-Vescan</surname><given-names>A</given-names></string-name>. <article-title>A historical overview upon the use of amphetamine derivatives in the treatment of obesity</article-title>. <source><italic toggle="yes">J Pharm Care</italic></source>. <year>2019</year>;<volume>7</volume>:<fpage>72</fpage>&#8211;<lpage>79</lpage>. doi:<pub-id pub-id-type="doi">10.18502/jpc.v7i3.2355</pub-id></mixed-citation></ref><ref id="cit0116"><label>116.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cercato</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Roizenblatt</surname><given-names>VA</given-names></string-name>, <string-name name-style="western"><surname>Leanca</surname><given-names>CC</given-names></string-name>, et al. <article-title>A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects</article-title>. <source><italic toggle="yes">Int J Obes (Lond)</italic></source>. <year>2009</year>;<volume>33</volume>(<issue>8</issue>):<fpage>857</fpage>&#8211;<lpage>865</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ijo.2009.124</pub-id><pub-id pub-id-type="pmid">19564877</pub-id></mixed-citation></ref><ref id="cit0117"><label>117.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Guo</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Garvey</surname><given-names>WT</given-names></string-name>. <article-title>Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: pooled results from Phase III clinical trials assessing phentermine/topiramate extended release</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2017</year>;<volume>40</volume>(<issue>7</issue>):<fpage>856</fpage>&#8211;<lpage>862</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc17-0088</pub-id><pub-id pub-id-type="pmid">28455281</pub-id><pub-id pub-id-type="pmcid">PMC5481985</pub-id></mixed-citation></ref><ref id="cit0118"><label>118.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Look</surname><given-names>M</given-names></string-name>, et al. <article-title>Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, Phase 3 extension study</article-title>. <source><italic toggle="yes">Am J Clin Nutr</italic></source>. <year>2012</year>;<volume>95</volume>(<issue>2</issue>):<fpage>297</fpage>&#8211;<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.3945/ajcn.111.024927</pub-id><pub-id pub-id-type="pmid">22158731</pub-id><pub-id pub-id-type="pmcid">PMC3260065</pub-id></mixed-citation></ref><ref id="cit0119"><label>119.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Nuako</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Reyes</surname><given-names>KJC</given-names></string-name>, <string-name name-style="western"><surname>Chhabria</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Stanford</surname><given-names>FC</given-names></string-name>. <article-title>Pharmacologic treatment of obesity in reproductive aged women</article-title>. <source><italic toggle="yes">Curr Obstet Gynecol Rep</italic></source>. <year>2023</year>;<volume>12</volume>(<issue>2</issue>):<fpage>138</fpage>&#8211;<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13669-023-00350-1</pub-id><pub-id pub-id-type="pmid">37427372</pub-id><pub-id pub-id-type="pmcid">PMC10328448</pub-id></mixed-citation></ref><ref id="cit0120"><label>120.</label><mixed-citation publication-type="book"><collab>Lomaira (phentermine hydrocloride USP)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>KVK-Tech, Inc</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="cit0121"><label>121.</label><mixed-citation publication-type="book"><collab>Qsymia (Phentermine and Topiramate Extended-Release)</collab>. <source><italic toggle="yes">Package Insert</italic></source>. <publisher-name>Vivus, LLC</publisher-name>; <year>2023</year>.</mixed-citation></ref><ref id="cit0122"><label>122.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Greenway</surname><given-names>FL</given-names></string-name>, <string-name name-style="western"><surname>Whitehouse</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Guttadauria</surname><given-names>M</given-names></string-name>, et al. <article-title>Rational design of a combination medication for the treatment of obesity</article-title>. <source><italic toggle="yes">Obesity (Silver Spring)</italic></source>. <year>2009</year>;<volume>17</volume>(<issue>1</issue>):<fpage>30</fpage>&#8211;<lpage>39</lpage>. doi:<pub-id pub-id-type="doi">10.1038/oby.2008.461</pub-id><pub-id pub-id-type="pmid">18997675</pub-id></mixed-citation></ref><ref id="cit0123"><label>123.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Apovian</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Aronne</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rubino</surname><given-names>D</given-names></string-name>, et al. <article-title>A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)</article-title>. <source><italic toggle="yes">Obesity (Silver Spring)</italic></source>. <year>2013</year>;<volume>21</volume>(<issue>5</issue>):<fpage>935</fpage>&#8211;<lpage>943</lpage>. doi:<pub-id pub-id-type="doi">10.1002/oby.20309</pub-id><pub-id pub-id-type="pmid">23408728</pub-id><pub-id pub-id-type="pmcid">PMC3739931</pub-id></mixed-citation></ref><ref id="cit0124"><label>124.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Roberto da Silva</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Carneiro</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Barbosa</surname><given-names>MP</given-names></string-name>, et al. <article-title>Naltrexone/bupropion modifies weight, food intake, and Drd2 gene expression in rats</article-title>. <source><italic toggle="yes">J Endocrinol</italic></source>. <year>2022</year>;<volume>253</volume>(<issue>3</issue>):<fpage>85</fpage>&#8211;<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.1530/JOE-21-0393</pub-id><pub-id pub-id-type="pmid">35302951</pub-id></mixed-citation></ref><ref id="cit0125"><label>125.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Levy</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Daniels</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hudson</surname><given-names>R</given-names></string-name>, et al. <article-title>Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats</article-title>. <source><italic toggle="yes">Neuropharmacology</italic></source>. <year>2018</year>;<volume>135</volume>:<fpage>547</fpage>&#8211;<lpage>554</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.01.035</pub-id><pub-id pub-id-type="pmid">29408463</pub-id></mixed-citation></ref><ref id="cit0126"><label>126.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Onakpoya</surname><given-names>IJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Mahtani</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Aronson</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Heneghan</surname><given-names>CJ</given-names></string-name>. <article-title>Naltrexone-bupropion (Mysimba) in management of obesity: a systematic review and meta-analysis of unpublished clinical study reports</article-title>. <source><italic toggle="yes">Br J Clin Pharmacol</italic></source>. <year>2020</year>;<volume>86</volume>(<issue>4</issue>):<fpage>646</fpage>&#8211;<lpage>667</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bcp.14210</pub-id><pub-id pub-id-type="pmid">31918448</pub-id><pub-id pub-id-type="pmcid">PMC7098870</pub-id></mixed-citation></ref><ref id="cit0127"><label>127.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fujioka</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Plodkowski</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Neil</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Gilder</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Greenway</surname><given-names>FL</given-names></string-name>. <article-title>The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy</article-title>. <source><italic toggle="yes">Int J Obes (Lond)</italic></source>. <year>2016</year>;<volume>40</volume>(<issue>9</issue>):<fpage>1369</fpage>&#8211;<lpage>1375</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ijo.2016.67</pub-id><pub-id pub-id-type="pmid">27328752</pub-id></mixed-citation></ref><ref id="cit0128"><label>128.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jorenby</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Hatsukami</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SS</given-names></string-name>, et al. <article-title>Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain</article-title>. <source><italic toggle="yes">Psychopharmacology (Berl)</italic></source>. <year>1996</year>;<volume>128</volume>(<issue>2</issue>):<fpage>130</fpage>&#8211;<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s002130050118</pub-id><pub-id pub-id-type="pmid">8956374</pub-id></mixed-citation></ref><ref id="cit0129"><label>129.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hartmann-Boyce</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Theodoulou</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Farley</surname><given-names>A</given-names></string-name>, et al. <article-title>Interventions for preventing weight gain after smoking cessation</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2021</year>;<volume>10</volume>(<issue>10</issue>):<fpage>CD006219</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD006219.pub4</pub-id><pub-id pub-id-type="pmid">34611902</pub-id><pub-id pub-id-type="pmcid">PMC8493442</pub-id></mixed-citation></ref><ref id="cit0130"><label>130.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lengsfeld</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Burkard</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Meienberg</surname><given-names>A</given-names></string-name>, et al. <article-title>Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial</article-title>. <source><italic toggle="yes">EClinicalMedicine</italic></source>. <year>2023</year>;<volume>57</volume>:<fpage>101865</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101865</pub-id><pub-id pub-id-type="pmid">36874396</pub-id><pub-id pub-id-type="pmcid">PMC9981899</pub-id></mixed-citation></ref><ref id="cit0131"><label>131.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Luthi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lengsfeld</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Burkard</surname><given-names>T</given-names></string-name>, et al. <article-title>Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial</article-title>. <source><italic toggle="yes">EClinicalMedicine</italic></source>. <year>2024</year>;<volume>68</volume>:<fpage>102429</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eclinm.2024.102429</pub-id><pub-id pub-id-type="pmid">38371479</pub-id><pub-id pub-id-type="pmcid">PMC10873660</pub-id></mixed-citation></ref><ref id="cit0132"><label>132.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wilcox</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Oskooilar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Erickson</surname><given-names>JS</given-names></string-name>, et al. <article-title>An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2010</year>;<volume>35</volume>(<issue>3</issue>):<fpage>229</fpage>&#8211;<lpage>234</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2009.10.017</pub-id><pub-id pub-id-type="pmid">19926400</pub-id></mixed-citation></ref><ref id="cit0133"><label>133.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Welling</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>de Groot</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Mohseni</surname><given-names>M</given-names></string-name>, et al. <article-title>Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study</article-title>. <source><italic toggle="yes">EClinicalMedicine</italic></source>. <year>2024</year>;<volume>74</volume>:<fpage>102709</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eclinm.2024.102709</pub-id><pub-id pub-id-type="pmid">39050109</pub-id><pub-id pub-id-type="pmcid">PMC11268126</pub-id></mixed-citation></ref><ref id="cit0134"><label>134.</label><mixed-citation publication-type="webpage"><string-name name-style="western"><surname>Le Roux</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Fitzgerald</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Neff</surname><given-names>K</given-names></string-name>. <article-title>ASOI adult obesity clinical practice guideline adaptation</article-title>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://asoi.info/guidelines/pharmacotherapy/" ext-link-type="uri">https://asoi.info/guidelines/pharmacotherapy/</ext-link>. <date-in-citation>Accessed <month>July</month><day>25</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0135"><label>135.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pankova</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kralikova</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zvolska</surname><given-names>K</given-names></string-name>, et al. <article-title>Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study</article-title>. <source><italic toggle="yes">BMJ Open</italic></source>. <year>2018</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e023987</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2018-023987</pub-id><pub-id pub-id-type="pmcid">PMC6303564</pub-id><pub-id pub-id-type="pmid">30559159</pub-id></mixed-citation></ref><ref id="cit0136"><label>136.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Scherr</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Seifert</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kuster</surname><given-names>M</given-names></string-name>, et al. <article-title>Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation</article-title>. <source><italic toggle="yes">BMC Public Health</italic></source>. <year>2015</year>;<volume>15</volume>:<fpage>520</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12889-015-1854-7</pub-id><pub-id pub-id-type="pmid">26025035</pub-id><pub-id pub-id-type="pmcid">PMC4448294</pub-id></mixed-citation></ref><ref id="cit0137"><label>137.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Mechanick</surname><given-names>JI</given-names></string-name>, <string-name name-style="western"><surname>Brett</surname><given-names>EM</given-names></string-name>, et al. <article-title>American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity</article-title>. <source><italic toggle="yes">Endocr Pract</italic></source>. <year>2016</year>;<volume>22</volume>(<issue>Suppl 3</issue>):<fpage>1</fpage>&#8211;<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.4158/EP161365.GL</pub-id><pub-id pub-id-type="pmid">27219496</pub-id></mixed-citation></ref><ref id="cit0138"><label>138.</label><mixed-citation publication-type="webpage"><string-name name-style="western"><surname>Pederson</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Manjoo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wharton</surname><given-names>S</given-names></string-name>. <article-title>Canadian adult obesity clinical practice guidelines: pharmacotherapy for obesity management</article-title>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://obesitycanada.ca/guidelines/pharmacotherapy" ext-link-type="uri">https://obesitycanada.ca/guidelines/pharmacotherapy</ext-link>. <date-in-citation>Accessed <month>June</month><day>26</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0139"><label>139.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Apovian</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Aronne</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Bessesen</surname><given-names>DH</given-names></string-name>, et al. <article-title>Pharmacological management of obesity guideline resources</article-title>. <publisher-name>The Endocrine Society</publisher-name>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.endocrine.org/clinical-practice-guidelines/pharmacological-management-of-obesity" ext-link-type="uri">https://www.endocrine.org/clinical-practice-guidelines/pharmacological-management-of-obesity</ext-link>. <date-in-citation>Accessed <month>June</month><day>26</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0140"><label>140.</label><mixed-citation publication-type="webpage"><string-name name-style="western"><surname>Glazer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Biertho</surname><given-names>L</given-names></string-name>. <article-title>Canadian adult obesity clinical practice guidelines: bariatric surgery: selection &amp; pre-operative workup</article-title>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://obesitycanada.ca/guidelines/preop" ext-link-type="uri">https://obesitycanada.ca/guidelines/preop</ext-link>. <date-in-citation>Accessed <month>May</month><day>10</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0141"><label>141.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Brown</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Clarke</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Johnson Stoklossa</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sievenpiper</surname><given-names>C</given-names></string-name>. <article-title>Canadian adult obesity clinical practice guidelines: medical nutrition therapy in obesity management</article-title>. <publisher-name>Obesity Canada</publisher-name><comment>Updated October 21, 2022, Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://obesitycanada.ca/guidelines/nutrition" ext-link-type="uri">https://obesitycanada.ca/guidelines/nutrition</ext-link>. <date-in-citation>Accessed <month>May</month><day>10</day>, 2024</date-in-citation>.</mixed-citation></ref><ref id="cit0142"><label>142.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Davis</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Goldberg</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Manley</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Baker</surname><given-names>TB</given-names></string-name>. <article-title>Randomized trial on mindfulness training for smokers targeted to a disadvantaged population</article-title>. <source><italic toggle="yes">Subst Use Misuse</italic></source>. <year>2014</year>;<volume>49</volume>(<issue>5</issue>):<fpage>571</fpage>&#8211;<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10826084.2013.770025</pub-id><pub-id pub-id-type="pmid">24611852</pub-id><pub-id pub-id-type="pmcid">PMC3955013</pub-id></mixed-citation></ref><ref id="cit0143"><label>143.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>US Preventive Services Task Force</surname></string-name>, <string-name name-style="western"><surname>Krist</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Davidson</surname><given-names>KW</given-names></string-name>, et al. <article-title>Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2021</year>;<volume>325</volume>(<issue>3</issue>):<fpage>265</fpage>&#8211;<lpage>279</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.25019</pub-id><pub-id pub-id-type="pmid">33464343</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>